Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrenkel Topping Regulatory News (FEN)

Share Price Information for Frenkel Topping (FEN)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £61.45m
FEN Live PriceLast checked at - London Stock Exchange

Intraday Frenkel Topping Share Chart

AGM Statement

19 May 2015 07:00

RNS Number : 5602N
Frenkel Topping Group PLC
19 May 2015
 

19 May 2015

Frenkel Topping Group plc

("Frenkel Topping" or "the Company")

 

AGM Statement

 

Frenkel Topping (AIM:FEN), a leading provider of specialist independent financial advice on the investment of personal injury damages and clinical negligence awards, will be holding its Annual General Meeting in Manchester at 10am today. 

 

At the meeting, David Southworth, Chairman of the Frenkel Topping, will make the following statement:

 

The current year has started well, with trading in line with expectations, as the Company focused on its stated objective of growing its geographic reach.

 

Since the year-end we have added 2 fee earners, taking the total to 16, compared to 14 as at 31 December 2014. AUM has grown to approximately £640m during the first quarter, compared to £619m at the year end. As per our stated objective we expect recent hires to generate increases in AUM and recurring investment revenues as they develop their operations in 2016 and onwards.

 

We now have an established presence in Manchester, London, Birmingham, Leeds, Cardiff and Bristol. The regional expansion across England and Wales continues to develop as planned and, as previously stated, is expected to deliver accelerated growth from 2016 onwards.

 

Earlier this month we held an extremely successful Deputy Day in London, for Court of Protection specialists and experts, looking at the need to ensure freedom of choice, trust and effective decision making for clients. We will continue to host events aimed at further strengthening our relationships with advisers as we build on the progress we have made to date this year.

 

Our underlying fundamentals remain strong with a 99% client retention rate for our Investment Management Services providing high levels of revenue visibility, helping to underpin continued profitability and cash generation.

 

 

For further information:

 

Frenkel Topping Group Plc

www.frenkeltopping.co.uk

Richard Fraser, Chief Executive

Tel: 0161 886 8000

Julie Dean, Finance Director

 

 

 

Shore Capital

 

Pascal Keane / Patrick Castle

Tel: 020 7408 4090

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 or frenkeltopping@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Nick Rome

Mob: 07748 325 236

 

About Frenkel Topping: www.frenkeltopping.co.uk

 

Frenkel Topping provides specialist independent financial advice on the investment of personal injury damages and clinical negligence awards. Frenkel Topping offers a complete service for all personal injury claims handlers, lawyers and individual clients, dealing with awards from a few thousand pounds to multi-million pound cases. The Company is a well recognised provider of expert witness reports in these cases and is then able to offer financial advice following settlement of the claim.

 

The Company's expertise includes asset protection, bespoke investment portfolios, analysis of periodical payments, Court of Protection portfolios and provision and setting up of trustee and receivership bank accounts.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMPKFDPPBKDAPD
Date   Source Headline
23rd Aug 201911:56 amRNSHolding(s) in Company
15th Jul 20192:14 pmRNSFrenkel Topping comment re: Ogden rate
3rd Jun 20197:00 amRNSAppointment of Tatton Asset Management to Ascencia
30th May 201912:35 pmRNSResult of AGM
30th May 20197:00 amRNSAGM Statement
9th May 20197:00 amRNSFrenkel Topping Deputy Day
10th Apr 20197:00 amRNSFinal Results
5th Mar 20196:04 pmRNSTransaction in own shares and TVR
1st Feb 20194:12 pmRNSTransaction in Own Shares
31st Jan 20197:00 amRNSPre Close Trading Update
13th Dec 20187:00 amRNSTransaction in own shares and TVR
4th Dec 20189:27 amRNSTransaction in Own Shares and TVR
22nd Nov 20184:47 pmRNSDirector/PDMR Shareholding
22nd Nov 20187:00 amRNSShare Buy Back Programme
14th Nov 201810:19 amRNSDirector/PDMR Shareholding
13th Nov 20187:00 amRNSTrading Update
5th Sep 20187:00 amRNSInterim Results
27th Jul 20182:27 pmRNSHolding(s) in Company
11th Jul 20187:00 amRNSBusiness and trading update
19th Jun 20188:00 amRNSAppointment of Joint Broker
19th Jun 20187:00 amRNSBoard Changes
11th Apr 20182:00 pmRNSDirector/PDMR Shareholding
9th Apr 20188:25 amRNSFinal Results
20th Mar 20187:00 amRNSNotice of Results
7th Feb 20187:00 amRNSAppointment of Portfolio Research Partner
20th Dec 20177:00 amRNSStrategic Update
18th Dec 20177:00 amRNSTransaction in Own Shares
15th Dec 20177:00 amRNSShare Buyback, Director Dealing & Resignation
1st Dec 20177:00 amRNSEmployee Benefit Trust Purchase
14th Nov 20177:00 amRNSTrading Update
2nd Oct 20177:00 amRNSDirectorate Appointment and Board Change
28th Sep 201711:00 amRNSHolding(s) in Company
22nd Sep 20172:16 pmRNSHolding(s) in Company
21st Sep 20171:11 pmRNSHolding(s) in Company
20th Sep 20175:21 pmRNSHolding(s) in Company
20th Sep 20174:46 pmRNSHolding(s) in Company
20th Sep 20174:44 pmRNSHolding(s) in Company
20th Sep 20174:42 pmRNSHolding(s) in Company
18th Sep 20179:26 amRNSPCA Dealing & Concert Party Update
6th Sep 20177:00 amRNSDirector/PDMR Shareholding
7th Aug 20177:00 amRNSDirectorate Change
1st Aug 20178:45 amRNSDirector Dealing
18th Jul 201710:17 amRNSDirector/PDMR Shareholding
13th Jul 20178:19 amRNSHolding(s) in Company
6th Jul 201710:01 amRNSHolding(s) in Company
5th Jul 20171:53 pmRNSExercise of Options and Concert Party Update
5th Jul 20177:00 amRNSHalf-year Report
3rd Jul 20177:00 amRNSRepayment of £3m SPV Loan
27th Jun 20175:31 pmRNSForm 8.3 - Brown Shipley & Co Ltd
27th Jun 20175:30 pmRNSForm 8.3 - Brown Shipley & Co Ltd

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.